MPS-5.4 Reduce emergency department (ED) visits for medication overdoses among children less than 5 years of age
About the Data
Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Estimated number of ED visits for medication overdoses among children <5 years of age
Estimated number of children in the U.S.<5 years of age
The denominator measure for the indicator: “Reduce emergency department (ED) visits for medication overdoses among children <5 years of age” is different than the denominator for the other indicators regarding rate of ED visits for medication overdose.
The denominator for this measure is the U.S. resident population of children <5 years of age (rather than a measure of medications prescribed for these children) because over 80% of ED visits for overdoses among children <5 years old are due to unsupervised ingestions, very often ingestion of medications prescribed or intended to be used by another older child or an adult. Thus, the population of children <5 years of age (rather than children <5 years of age who are prescribed medications) is the best measure of the population at risk.
To calculate the numerator: The cause/mechanism of each adverse drug event visit is coded as allergic reaction, side-effect or overdose. Only ED visits due to overdoses are included in the numerator.
CENSUS NOTE FOR MULTIPLE DATA YEARS: Population denominators for emergency department visit rates are calculated based on sums of the bridged-race estimates of the U.S. resident populations for each of the data years involved (e.g., the denominator of a rate for 2009-2010 combined is the sum of the population estimates for 2009 and 2010). For census years (e.g. 2010), population counts enumerated as of July 1 are used. Intercensal population estimates are used in rate calculations for the years between censuses (e.g. 1991-1999, 2001-2009).
Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.
Additional resources about the objective
- Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66.
- Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, Pollock DA. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008;152: 416-421.
- Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (NEISS-CADES). Medical Care 2007;45 (suppl 2):S96-S102.